Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease.

Frontiers in Cellular and Infection Microbiology
Jing LiuLei Shao

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by neuronal loss and dysfunction of dopaminergic neurons located in the substantia nigra, which contain a variety of misfolded α-synuclein (α-syn). Medications that increase or substitute for dopamine can be used for the treatment of PD. Recently, numerous studies have shown gut microbiota plays a crucial role in regulating and maintaining multiple aspects of host physiology including host metabolism and neurodevelopment. In this review article, the role of gut microbiota in the etiological mechanism of PD will be reviewed. Furthermore, we discussed current pharmaceutical medicine-based methods to prevent and treat PD, followed by describing specific strains that affect the host brain function through the gut-brain axis. We explained in detail how gut microbiota directly produces neurotransmitters or regulate the host biosynthesis of neurotransmitters. The neurotransmitters secreted by the intestinal lumen bacteria may induce epithelial cells to release molecules that, in turn, can regulate neural signaling in the enteric nervous system and subsequently control brain function and behavior through the brain-gut axis. Finally, we proved that the mi...Continue Reading

References

May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniM Goedert
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Apr 4, 2003·The New England Journal of Medicine·Robert L Nussbaum, Christopher E Ellis
Nov 25, 2003·The Journal of Biological Chemistry·Mikiei TanakaM Maral Mouradian
Dec 30, 2003·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Rinat TabakmanPhilip Lazarovici
Jul 24, 2004·Nature Medicine·Miquel Vila, Serge Przedborski
May 23, 2006·Lancet Neurology·Lonneke M L de Lau, Monique M B Breteler
Dec 21, 2006·Nature Reviews. Neuroscience·Michelle L BlockJau-Shyong Hong
Apr 10, 2007·Trends in Neurosciences·David Sulzer
Apr 18, 2007·Journal of Neurochemistry·Inmaculada RiteJosé L Venero
May 25, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Robert D AbbottLon R White
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Oct 3, 2007·Clinical Neuropharmacology·C Warren Olanow, Paul B Watkins
Oct 27, 2007·Neuropathology and Applied Neurobiology·C H HawkesH Braak
Jun 19, 2008·Genes & Development·Der-Fen SuenRichard J Youle
Jul 9, 2008·Parkinsonism & Related Disorders·Mussadiq ShahChristopher H Hawkes
Oct 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Harry SokolPhilippe Langella
Dec 17, 2008·Nutrition Research·Andreas BenderThomas Klopstock
Feb 21, 2009·Current Medical Research and Opinion·Rajesh Pahwa, Kelly E Lyons
Apr 14, 2009·Trends in Pharmacological Sciences·Olle Lindvall, Zaal Kokaia
Jan 20, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jaime Kulisevsky, Javier Pagonabarraga
Jan 30, 2010·Parkinsonism & Related Disorders·Dennis W DicksonJ Eric Ahlskog
Feb 2, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ashley D ReynoldsHoward E Gendelman
Feb 23, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Charles H AdlerThomas G Beach
Feb 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Shen-Yang Lim, Anthony E Lang
Mar 4, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Elisabeth WolfWerner Poewe
Mar 23, 2010·Cell·Christopher K GlassFred H Gage
Jun 4, 2010·The New England Journal of Medicine·Kenneth A FollettUNKNOWN CSP 468 Study Group
Aug 24, 2010·Mitochondrion·Clare Sheridan, Seamus J Martin
Oct 22, 2010·Amino Acids·Shripad N Surwase, Jyoti P Jadhav
Dec 25, 2010·Therapeutic Advances in Neurological Disorders·Stuart H Isaacson, Robert A Hauser

❮ Previous
Next ❯

Citations

May 27, 2021·New Microbes and New Infections·S R MansourA-R A Moustafa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

Bioscience of Microbiota, Food and Health
Gizem Özata Uyar, Hilal Yildiran
Cellular and Molecular Neurobiology
Nitu DograDeepshikha Pande Katare
© 2021 Meta ULC. All rights reserved